• The Precision Peptide Company signed an exclusive strategic marketing agreement with Mixed Martial Arts Group (MMA.INC) in May 2026.
• Deal gives exclusive rights to market peptide products across MMA.INC’s digital platform, reaching more than 5 million social followers.
• Net revenue share set at 50/50 for the first 12 months, shifting to 75/25 in Precision Peptide’s favor from month 13.
• No upfront capital investment; a 12-month post-termination tail applies for revenue share on referred customers.
• Update comes ahead of Conor McGregor’s scheduled UFC 329 return on July 11, 2026, a potential catalyst for platform engagement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Precision Peptide Company Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202607080700TNWSWRCACNPR_____1LpMF00Rx) on July 08, 2026, and is solely responsible for the information contained therein.